RAIDD Antibodies

Santa Cruz Biotechnology delivers a wide array of RAIDD monoclonal antibodies for advanced research in apoptosis and immune response. RAIDD monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RAIDD (RIP-associated ICH-1/CED-3-homologous protein) plays a critical role in mediating apoptotic signaling pathways, particularly in response to death receptor activation. By linking death receptors to caspase activation, RAIDD is essential for the regulation of programmed cell death, which is vital for maintaining cellular homeostasis and immune system function. Understanding RAIDD's role in cellular processes can provide insights into various diseases, including cancer and autoimmune disorders. Researchers worldwide rely on RAIDD monoclonal antibodies to advance their studies in cell death pathways and immune system regulation. RAIDD monoclonal antibodies enable detailed investigation of protein interactions and signaling cascades in various experimental settings. The high specificity of RAIDD monoclonal antibodies from Santa Cruz Biotechnology continues to support breakthrough discoveries in cell death research and therapeutic development.